title: A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.
authors.affiliation: Department of Medicine and UCLA AIDS Institute, Los Angeles, CA 90095-1678, USA.
authors.forename: R G
authors.initials: RG
authors.lastname: Amado
authors.forename: R T
authors.initials: RT
authors.lastname: Mitsuyasu
authors.forename: G
authors.initials: G
authors.lastname: Symonds
authors.forename: J D
authors.initials: JD
authors.lastname: Rosenblatt
authors.forename: J
authors.initials: J
authors.lastname: Zack
authors.forename: L Q
authors.initials: LQ
authors.lastname: Sun
authors.forename: M
authors.initials: M
authors.lastname: Miller
authors.forename: J
authors.initials: J
authors.lastname: Ely
authors.forename: W
authors.initials: W
authors.lastname: Gerlach
mesh_terms: D000293:Adolescent; D000328:Adult; D018952:Antigens, CD34; D002478:Cells, Cultured; D002985:Clinical Protocols; D015696:Gene Products, tat / Q000235:genetics*; D015316:Genetic Therapy; D015658:HIV Infections / Q000628:therapy* / Q000821:virology; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism*; D006805:Human Experimentation; D006801:Humans; D008875:Middle Aged; D016337:RNA, Catalytic / Q000235:genetics*; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D018952:Antigens, CD34; D015696:Gene Products, tat; D016337:RNA, Catalytic; D054322:tat Gene Products, Human Immunodeficiency Virus